HIV pre-exposure prophylaxis in transgender women: A subgroup analysis of the iPrEx trial

• Main Authors: Madeline B. Deutsch, David V. Glidden, Jae Sevelius, Joanne Keatley, Vanessa McMahan, Juan Guanira, Esper G. Kallas, Suwat Chariyalertsak, Robert M. Grant, Javier Lama, Mauro Schechter, Valdilea Veloso, Linda Gail Bekker, Kenneth Mayer, Susan Buchbinder, Orlando Montoya, Martin Casapia, Sybil Hosek, Albert Liu, Rivet Amico, Kimberly Koester, Kathleen Mulligan
• 格式: 雜誌
• 出版: 2018
• 主題: Agricultural and Biological Sciences
• 在線閱讀: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84959932232&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/44053

© 2015 Elsevier Ltd. Background: Pre-exposure prophylaxis (PrEP) with oral emtricitabine and tenofovir disoproxil fumarate is used to prevent the sexual acquisition of HIV in groups at high risk such as transgender women. We used data from the iPrEx study to assess PrEP efficacy, effectiveness, and...